Ozempic shortages in the EU will not affect all Member States
An intermittent shortage of the diabetes drug Ozempic in the European Union, which is expected to persist into the last quarter of 2024 due to high demand, will not affect all member states, Danish pharmaceutical company Novo Nordisk said.
ПОПУЛЯРНЫЕ ПОСТЫ
Bluetongue outbreak in a Portuguese sheep farm has broken out
Сентябрь 19, 2024
Austria says disaster fund to rise to 1 billion euros
Сентябрь 19, 2024
Portugal gets help from Spain and Morocco in response to fires
Сентябрь 19, 2024
Drought reduces Amazon rivers to historic lows
Сентябрь 19, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ